From: Integrative relational machine-learning for understanding drug side-effect profiles
SEP | DT | ILP | ||||
---|---|---|---|---|---|---|
Acc | Spec | Sens | Acc | Spec | Sens | |
SEP_1 | 0.65 | 0.86 | 0.39 | 0.61 | 0.63 | 0.6 |
SEP_2 | 0.69 | 0.88 | 0.4 | 0.63 | 0.69 | 0.54 |
SEP_3 | 0.71 | 0.88 | 0.47 | 0.71 | 0.77 | 0.63 |
SEP_4 | 0.66 | 0.89 | 0.32 | 0.62 | 0.7 | 0.51 |
SEP_5 | 0.68 | 0.88 | 0.38 | 0.64 | 0.7 | 0.54 |
SEP_6 | 0.68 | 0.87 | 0.39 | 0.61 | 0.69 | 0.49 |
SEP_7 | 0.65 | 0.86 | 0.32 | 0.6 | 0.67 | 0.49 |
SEP_8 | 0.7 | 0.87 | 0.44 | 0.67 | 0.73 | 0.57 |
SEP_9 | 0.69 | 0.84 | 0.46 | 0.69 | 0.75 | 0.59 |
SEP_10 | 0.7 | 0.89 | 0.4 | 0.65 | 0.76 | 0.47 |
SEP_11 | 0.7 | 0.88 | 0.44 | 0.7 | 0.82 | 0.45 |
SEP_12 | 0.71 | 0.88 | 0.45 | 0.7 | 0.76 | 0.61 |
SEP_13 | 0.67 | 0.88 | 0.35 | 0.66 | 0.74 | 0.54 |
SEP_14 | 0.69 | 0.89 | 0.39 | 0.63 | 0.71 | 0.51 |
SEP_15 | 0.71 | 0.9 | 0.43 | 0.69 | 0.76 | 0.6 |
SEP_16 | 0.69 | 0.89 | 0.39 | 0.66 | 0.72 | 0.57 |
SEP_17 | 0.74 | 0.89 | 0.52 | 0.65 | 0.74 | 0.51 |
SEP_18 | 0.65 | 0.87 | 0.34 | 0.61 | 0.69 | 0.5 |
SEP_19 | 0.74 | 0.91 | 0.47 | 0.72 | 0.77 | 0.64 0 |
SEP_20 | 0.71 | 0.89 | 0.44 | 0.64 | 0.73 | 0.51 |
SEP_21 | 0.72 | 0.9 | 0.46 | 0.64 | 0.72 | 0.54 |
SEP_22 | 0.65 | 0.88 | 0.32 | 0.61 | 0.69 | 0.48 |
SEP_23 | 0.71 | 0.89 | 0.43 | 0.63 | 0.7 | 0.51 |
SEP_24 | 0.68 | 0.87 | 0.4 | 0.62 | 0.71 | 0.5 |
SEP_25 | 0.71 | 0.9 | 0.43 | 0.65 | 0.72 | 0.56 |
SEP_26 | 0.69 | 0.88 | 0.4 | 0.62 | 0.69 | 0.52 |
Average | 0.67 | 0.83 | 0.43 | 0.65 | 0.72 | 0.54 |